PRINCETON, N.J., May 2, 2011 /PRNewswire/ -- BullMarket.com
(http://www.bullmarket.com), an online investment newsletter
focused on long-term growth and income-generating stocks, has
provided subscribers with coverage of several chemical stocks,
including DuPont (NYSE: DD), Eastman Chemical (NYSE: EMN), Dow
Chemical (NYSE: DOW), and LyondellBasell Industries (NYSE:
LYB).
As a subscriber, you'll also gain access to our Recommended List
of stocks, which was up over 20% in 2010, up 40% in 2009, and
outperformed the S&P by 15% in 2008.
All trial subscribers will also receive BMR's weekly earning
previews during earnings season (26+ in total), annual High Yield
Special Report, and annual MLP Special Report.
Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/pr/?refer=BMR335P
BMR looked at the following topics, among others:
-- What did BMR like about Eastman Chemical before it reported
its Q1 results?
-- While DuPont trades at a premium to other chemical makers,
does its valuation look justified? Can the stock continue its
strong run?
-- While the timing of its purchase of Rohm Haas wasn't the best, does the deal look
like it will turn out to be a good one for Dow Chemical?
-- What advantage does LyondellBasell have that makes the stock
look attractive? Why was BMR bullish on the stock ahead of
earnings?
About BullMarket.com:
Launched in 1997, BullMarket.com has a strong track record of
creating wealth for its subscribers by providing sound, long-term
investing advice. The BullMarket.com Recommended List includes
about 50 companies across all major industries, including
Financials, Healthcare, Energy, Technology, and Retail, among
others. BullMarket.com is one of the oldest continuously published
investment newsletters online, and its Recommended List has
consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC
(CRD #131926), a registered investment advisor with the NASD and
State of NJ. Past performance does
not guarantee future results. Investors should always research
companies and securities before making any investments. Nothing
herein should be construed as an offer or solicitation to buy or
sell any security.
Contact:
Indie Research Advisors, LLC
Marcie Martin, +1-888-278-5515
SOURCE Indie Research Advisors, LLC